COVID-19

The era of social distancing will likely leave a lasting impression on telehealth services, as HCPs quickly learn to incorporate it as a valuable tool and adapt to changes.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

The current state of oncology is shaping challenges for the future specifically in the areas of telehealth, home infusions, and a surge of new patients that have not been to oncology clinics yet.

Panic and a host of interactions are entwined with disease-modifying antirheumatic drugs.

Experts discuss what their teams have learned throughout the COVID-19 pandemic, during the COA virtual conference.

Solving challenges of the current system is vital to spreading clinical trials into community clinics, which may be increasingly important.

Patients with cardiovascular disease who develop COVID-19 have a higher risk of mortality, according to a SCAI press release.

With additional state action to remove testing restrictions, pharmacists will be able to continue their work to serve on the frontlines of health care during this pandemic.

Two case studies have highlighted the use of tele-diabetes to manage new-onset type 1 diabetes (T1D) cases in an adult and an infant during the coronavirus disease 2019 (COVID-19) pandemic.

A new study indicates that treatment with hydroxychloroquine increases overall mortality in patients hospitalized with COVID-19.

The FDA has approved the first diagnostic test with a home collection option for the coronavirus disease 2019.

The new guidance authorizes licensed pharmacists to order and administer COVID-19 tests, including serology tests, that are approved by the FDA.

Pharmacy Times® invites you to join us and experts in pharmacy to gain insight into the value pharmacists provide in treating patients throughout the pandemic.

More than 53% of survey respondents reported having a diversion event within the last year, in addition to 37% who were aware of at least 1 colleague who has diverted controlled substances.

Oncology/Hematology pharmacists from Boston Medical Center discuss how COVID-19 has affected their patients.

Today, we’re thanking Angela Garcia, PharmD, MPH, CPh, for her work as an American Pharmacists Association–Academy of Student Pharmacists (APhA-ASP) chapter advisor.

An overview of the most recent legal developments related to COVID-19 that are relevant to pharmacies.

Widely used medications for patients with HIV/AIDS may be potential treatments for the coronavirus disease 2019 should the drugs demonstrate safety and efficacy in clinical trials.

Adam Martin, PharmD, founder of the Fit Pharmacist, discusses tips for staying hopeful and motivated.

Many health care companies are taking the opportunity to deliver testing kits to local pharmacies to properly equip pharmacists with the right resources during the pandemic.

A new study found that alternative swab materials and commonly available saline are effective for COVID-19 testing, allowing patients to self-administer tests.

New research has found that hospitalized patients with COVID-19, diabetes, and/or uncontrolled hyperglycemia have significantly higher mortality rates.

Loss of smell and taste has been anecdotally linked to COVID-19 infections, according to a study that reported the first empirical findings that strongly associate sensory loss with coronavirus disease 2019.

Pharmacists have the opportunity during the COVID-19 outbreak to show who we really are.

Brooke Griffin, PharmD, BCACP, discusses the 21st Century PharmD and how students are responding to COVID-19.